iShares Nasdaq Biotechnology Index Fund ETF Forecast

iShares Nasdaq Biotechnology Index Fund ETF downgraded to Sell Candidate
(Updated on Apr 23, 2024)

IBB Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 2.71%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The iShares Nasdaq Biotechnology Index Fund ETF holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the ETF giving a more negative forecast for the stock. On further gains, the ETF will meet resistance from the long-term Moving Average at $133.72. On a fall, the ETF will find some support from the short-term average at $126.31. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for iShares Nasdaq Biotechnology Index Fund ETF

iShares Nasdaq Biotechnology Index Fund finds support from accumulated volume at $127.84 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This ETF has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the ETF moved $2.29 between high and low, or 1.81%. For the last week, the ETF has had daily average volatility of 1.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IBB) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect iShares Nasdaq Biotechnology Index Fund to open at $127.83, and during the day (based on 14 day Average True Range), to move between $125.91 and $130.13, which gives a possible trading interval of +/-$2.11 (+/-1.65%) up or down from last closing price. If iShares Nasdaq Biotechnology Index Fund takes out the full calculated possible swing range there will be an estimated 3.29% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $127.84 (0.14%) than the resistance at $134.80 (5.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is iShares Nasdaq Biotechnology Index Fund ETF A Buy?

iShares Nasdaq Biotechnology Index Fund holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this ETF. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.282 Sell Candidate Downgraded

Predicted Opening Price for iShares Nasdaq Biotechnology Index Fund of Wednesday, April 24, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.